| Year |
Citation |
Score |
| 2024 |
Gharzai LA, Morris E, Suresh K, Nguyen-Tân PF, Rosenthal DI, Gillison ML, Harari PM, Garden AS, Koyfman S, Caudell JJ, Jones CU, Mitchell DL, Krempl G, Ridge JA, Gensheimer MF, et al. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis. The Lancet. Oncology. 25: 366-375. PMID 38423050 DOI: 10.1016/S1470-2045(24)00016-0 |
0.42 |
|
| 2024 |
D'Souza G, Tewari SR, Troy T, Webster-Cyriaque J, Wiley DJ, Lahiri CD, Palella FJ, Gillison ML, Strickler HD, Struijk L, Waterboer T, Ho K, Kwait J, Lazar J, Weber KM, et al. Oncogenic Oral Human Papillomavirus Clearance Patterns Over 10 years. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 38294704 DOI: 10.1158/1055-9965.EPI-23-1272 |
0.5 |
|
| 2023 |
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, ... ... Gillison ML, et al. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 3081-3088. PMID 37285653 DOI: 10.1200/JCO.22.02625 |
0.447 |
|
| 2023 |
Gillison ML. Flashback Foreword: Human Papillomavirus and Incidence and Survival of Oropharyngeal Cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 3079-3080. PMID 37285652 DOI: 10.1200/JCO.23.00224 |
0.333 |
|
| 2023 |
Akagi K, Symer DE, Mahmoud M, Jiang B, Goodwin S, Wangsa D, Li Z, Xiao W, Dunn JD, Ried T, Coombes KR, Sedlazeck FJ, Gillison ML. Intratumoral heterogeneity and clonal evolution induced by HPV integration. Cancer Discovery. PMID 36715691 DOI: 10.1158/2159-8290.CD-22-0900 |
0.391 |
|
| 2023 |
Landy R, Haber G, Graubard BI, Campos NG, Sy S, Kim JJ, Burger EA, Cheung LC, Katki HA, Gillison ML, Chaturvedi AK. Upper age-limits for US male HPV-vaccination for oropharyngeal cancer prevention: A microsimulation-based modeling study. Journal of the National Cancer Institute. PMID 36655795 DOI: 10.1093/jnci/djad009 |
0.496 |
|
| 2022 |
Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, et al. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 224-234. PMID 35276673 DOI: 10.6004/jnccn.2022.0016 |
0.358 |
|
| 2021 |
Symer DE, Akagi K, Geiger HM, Song Y, Li G, Emde AK, Xiao W, Jiang B, Corvelo A, Toussaint NC, Li J, Agrawal A, Ozer E, El-Naggar AK, Du Z, ... ... Gillison ML, et al. Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers. Genome Research. PMID 34903527 DOI: 10.1101/gr.275911.121 |
0.402 |
|
| 2021 |
Bigelow EO, Harris J, Fakhry C, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Frank SJ, Nair SG, Bahig H, Ridge JA, Caudell J, Donaldson C, Clifford BT, Shenouda G, Birrer MJ, et al. Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: A secondary analysis of NRG Oncology RTOG 0129 and 0522. Head & Neck. PMID 34729846 DOI: 10.1002/hed.26915 |
0.505 |
|
| 2021 |
Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Duvvuri U, O'Malley BW, Ozer E, Thomas GR, Koch WM, Gross ND, et al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101752. PMID 34699271 DOI: 10.1200/JCO.21.01752 |
0.402 |
|
| 2021 |
Giraldi L, Collatuzzo G, Hashim D, Franceschi S, Herrero R, Chen C, Schwartz SM, Smith E, Kelsey K, McClean M, Gillison M, Boccia S, Hashibe M, Amy Lee YC, Boffetta P. Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiology. 75: 102020. PMID 34509873 DOI: 10.1016/j.canep.2021.102020 |
0.483 |
|
| 2021 |
Shewale JB, Pickard RKL, Xiao W, Jiang B, Gillison ML. Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas. Cancer. PMID 33620741 DOI: 10.1002/cncr.33440 |
0.532 |
|
| 2020 |
D'Souza G, Clemens G, Strickler HD, Wiley DJ, Troy T, Struijk L, Gillison M, Fakhry C. Long-term Persistence of Oral HPV Over 7 Years of Follow-up. Jnci Cancer Spectrum. 4: pkaa047. PMID 33225205 DOI: 10.1093/Jncics/Pkaa047 |
0.513 |
|
| 2020 |
Kreimer AR, Chaturvedi AK, Alemany L, Anantharaman D, Bray F, Carrington M, Doorbar J, D'Souza G, Fakhry C, Ferris RL, Gillison M, Neil Hayes D, Hildesheim A, Huang SH, Kowalski LP, et al. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncology. 108: 104736. PMID 32502860 DOI: 10.1016/J.Oraloncology.2020.104736 |
0.457 |
|
| 2020 |
Mehanna H, Rischin D, Wong SJ, Gregoire V, Ferris R, Waldron J, Le QT, Forster M, Gillison M, Laskar S, Tahara M, Psyrri A, Vermorken J, Porceddu S. De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000056. PMID 32496903 DOI: 10.1200/JCO.20.00056 |
0.515 |
|
| 2020 |
Chaturvedi AK, Graubard BI, Gillison ML. Herd Protection Against Oral HPV Infection-Reply. Jama. 323: 478. PMID 32016305 DOI: 10.1001/Jama.2019.19727 |
0.461 |
|
| 2020 |
Broutian TR, Jiang B, Li J, Akagi K, Gui S, Zhou Z, Xiao W, Symer DE, Gillison ML. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma. Cancer Letters. PMID 31958486 DOI: 10.1016/j.canlet.2020.01.012 |
0.356 |
|
| 2019 |
Lee YA, Al-Temimi M, Ying J, Muscat J, Olshan AF, Zevallos JP, Winn DM, Li G, Sturgis EM, Morgenstern H, Zhang ZF, Smith E, Kelsey K, McClean M, Vaughan TL, ... ... Gillison M, et al. Head and Neck Cancer Risk Prediction Models for the US Population from the INHANCE Consortium. American Journal of Epidemiology. PMID 31781743 DOI: 10.1093/Aje/Kwz259 |
0.324 |
|
| 2019 |
Chaturvedi AK, Graubard BI, Broutian T, Xiao W, Pickard RKL, Kahle L, Gillison ML. Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016. Jama. 322: 977-979. PMID 31503300 DOI: 10.1001/Jama.2019.10508 |
0.454 |
|
| 2019 |
Shewale JB, Gillison ML. Dynamic factors affecting HPV-attributable fraction for head and neck cancers. Current Opinion in Virology. 39: 33-40. PMID 31465959 DOI: 10.1016/j.coviro.2019.07.008 |
0.533 |
|
| 2019 |
Fakhry C, Blackford AL, Neuner G, Xiao W, Jiang B, Agrawal A, Gillison ML. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Jama Oncology. PMID 31046104 DOI: 10.1001/jamaoncol.2019.0439 |
0.507 |
|
| 2019 |
Tota JE, Best AF, Zumsteg ZS, Gillison ML, Rosenberg PS, Chaturvedi AK. Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900370. PMID 31026209 DOI: 10.1200/Jco.19.00370 |
0.361 |
|
| 2019 |
Hernandez BY, Lynch CF, Chan OTM, Goodman MT, Unger ER, Steinau M, Thompson TD, Gillison M, Lyu C, Saraiya M. Human papillomavirus DNA detection, p16, and oral cavity cancer in a U.S. population. Oral Oncology. 91: 92-96. PMID 30926069 DOI: 10.1016/j.oraloncology.2019.03.001 |
0.44 |
|
| 2019 |
Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, et al. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Cancer. PMID 30913305 DOI: 10.1002/Cncr.32025 |
0.316 |
|
| 2019 |
Rindal DB, Gilbert G, Carcelén C, Funkhouser E, Durand E, Uppgaard DA, Fellows J, Ikeda J, Kerr AR, Brar B, Gordan VV, Agarwal S, Barnett P, Pickard RK, Gillison M, et al. Feasibility and acceptance of oral human papillomavirus detection in the dental office: Results from The National Dental Practice-Based Research Network. Journal of the American Dental Association (1939). 150: 130-139.e4. PMID 30691571 DOI: 10.1016/J.Adaj.2018.10.022 |
0.52 |
|
| 2019 |
Gleber-Netto FO, Rao X, Guo T, Xi Y, Gao M, Shen L, Erikson K, Kalu NN, Ren S, Xu G, Fisch KM, Akagi K, Seiwert T, Gillison M, Frederick MJ, et al. Variations in HPV function are associated with survival in squamous cell carcinoma. Jci Insight. 4. PMID 30626753 DOI: 10.1172/Jci.Insight.124762 |
0.525 |
|
| 2019 |
Gillison ML, Akagi K, Xiao W, Jiang B, Pickard RKL, Li J, Swanson BJ, Agrawal AD, Zucker M, Stache-Crain B, Emde AK, Geiger HM, Robine N, Coombes KR, Symer DE. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Research. 29: 1-17. PMID 30563911 DOI: 10.1101/Gr.241141.118 |
0.516 |
|
| 2019 |
Shewale JB, Pickard R, Gillison ML. Abstract 643: Poor oral hygiene is associated with HPV-negative and not HPV-positive oral cancer Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-643 |
0.591 |
|
| 2018 |
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). PMID 30449625 DOI: 10.1016/S0140-6736(18)32779-X |
0.415 |
|
| 2018 |
Coghill AE, Bellizzi AM, Lynch CF, Shiels MS, Selk FR, Gillison M, Hernandez BY, Chan OTM, Engels EA. Pathology characterization and detection of human papillomavirus type 16 in rectal squamous cell carcinomas. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 30448596 DOI: 10.1016/J.Cgh.2018.11.006 |
0.369 |
|
| 2018 |
Voltzke KJ, Lee YA, Zhang ZF, Zevallos JP, Yu GP, Winn DM, Vaughan TL, Sturgis EM, Smith E, Schwartz SM, Schantz S, Muscat J, Morgenstern H, McClean M, Li G, ... ... Gillison M, et al. Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium. Cancer Causes & Control : Ccc. PMID 29761303 DOI: 10.1007/S10552-018-1026-Z |
0.304 |
|
| 2018 |
Warburton A, Redmond CJ, Dooley KE, Fu H, Gillison ML, Akagi K, Symer DE, Aladjem MI, McBride AA. HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression. Plos Genetics. 14: e1007179. PMID 29364907 DOI: 10.1371/Journal.Pgen.1007179 |
0.517 |
|
| 2017 |
Börnigen D, Ren B, Pickard R, Li J, Ozer E, Hartmann EM, Xiao W, Tickle T, Rider J, Gevers D, Franzosa EA, Davey ME, Gillison ML, Huttenhower C. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Scientific Reports. 7: 17686. PMID 29247187 DOI: 10.1038/S41598-017-17795-Z |
0.38 |
|
| 2017 |
Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong ZY, Xiao W, Kahle L, Gillison ML. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017750141. PMID 29182497 DOI: 10.1200/Jco.2017.75.0141 |
0.537 |
|
| 2017 |
Kiyota N, Hasegawa Y, Takahashi S, Yokota T, Yen CJ, Iwae S, Shimizu Y, Hong RL, Goto M, Kang JH, Sum Kenneth Li W, Ferris RL, Gillison M, Namba Y, Monga M, et al. A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141. Oral Oncology. 73: 138-146. PMID 28939066 DOI: 10.1016/J.Oraloncology.2017.07.023 |
0.359 |
|
| 2017 |
Harrington KJ, Ferris RL, Blumenschein G, Colevas AD, Fayette J, Licitra L, Kasper S, Even C, Vokes EE, Worden F, Saba NF, Kiyota N, Haddad R, Tahara M, Grünwald V, ... ... Gillison ML, et al. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. The Lancet. Oncology. PMID 28651929 DOI: 10.1016/S1470-2045(17)30421-7 |
0.35 |
|
| 2017 |
Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. Human papillomavirus-related oropharyngeal cancer. Annals of Oncology. 28: 2386-2398. PMID 28633362 DOI: 10.1093/Annonc/Mdx304 |
0.609 |
|
| 2017 |
Yuan H, Krawczyk E, Blancato J, Albanese C, Zhou D, Wang N, Paul S, Alkhilaiwi F, Palechor-Ceron N, Dakic A, Fang S, Choudhary S, Hou TW, Zheng YL, Haddad BR, ... ... Gillison M, et al. HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes. Scientific Reports. 7: 45617. PMID 28378747 DOI: 10.1038/Srep45617 |
0.572 |
|
| 2017 |
Miller ED, Blakaj DM, Swanson BJ, Xiao W, Gillison ML, Wei L, Bhatt AD, Diavolitsis VM, Wobb JL, Kang SY, Carrau RL, Grecula JC. Sinonasal adenoid cystic carcinoma: Treatment outcomes and association with human papillomavirus. Head & Neck. PMID 28370900 DOI: 10.1002/Hed.24778 |
0.475 |
|
| 2017 |
Taberna M, Inglehart RC, Pickard RK, Fakhry C, Agrawal A, Katz ML, Gillison ML. Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer. Cancer. PMID 28195638 DOI: 10.1002/Cncr.30564 |
0.474 |
|
| 2017 |
Ferris R, Gillison ML. Nivolumab for Squamous-Cell Cancer of Head and Neck. The New England Journal of Medicine. 376: 596. PMID 28177863 DOI: 10.1056/Nejmc1615565 |
0.413 |
|
| 2017 |
Gillison ML, Ferris RL, Zhang Q, Colevas AD, Mell LK, Kong C, Jordan R, Moore K, Truong MT, Kirsch C, Machtay M, Curran WJ, Le Q. A randomized phase II study of chemoradiation (CRT) +/- nivolumab (Nivo) with sequential safety evaluations of Nivo +/- lirilumab (Liri) or ipilumumab (Ipi) concomitant with (C) RT in intermediate (IR) and high-risk (HR) head and neck squamous cell carcinoma (HNSCC) (RTOG 3504, NCT02764593). Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps6097 |
0.33 |
|
| 2017 |
Gillison ML, Broutian T, Graubard B, Pickard R, Tong Z, Xiao W, Kahle L, Chaturvedi A. Impact of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the U.S. Journal of Clinical Oncology. 35: 6003-6003. DOI: 10.1200/Jco.2017.35.15_Suppl.6003 |
0.508 |
|
| 2016 |
Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, et al. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016683300. PMID 28029303 DOI: 10.1200/Jco.2016.68.3300 |
0.467 |
|
| 2016 |
Inglehart RC, Taberna M, Pickard RK, Hoff M, Fakhry C, Ozer E, Katz M, Gillison ML. HPV knowledge gaps and information seeking by oral cancer patients. Oral Oncology. 63: 23-29. PMID 27938996 DOI: 10.1016/J.Oraloncology.2016.10.021 |
0.606 |
|
| 2016 |
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, et al. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. PMID 27906454 DOI: 10.1002/Cncr.30449 |
0.38 |
|
| 2016 |
Lam JO, Sugar EA, Cranston RD, Weber KM, Burk RD, Wiley DJ, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Coles CL, Bream JH, Rositch AF, Guo Y, ... ... Gillison ML, et al. The association of medication use with clearance or persistence of oral HPV infection. Cancer Causes & Control : Ccc. PMID 27804058 DOI: 10.1007/S10552-016-0826-2 |
0.57 |
|
| 2016 |
Wyss AB, Hashibe M, Lee YA, Chuang SC, Muscat J, Chen C, Schwartz SM, Smith E, Zhang ZF, Morgenstern H, Wei Q, Li G, Kelsey KT, McClean M, Winn DM, ... ... Gillison ML, et al. Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium. American Journal of Epidemiology. PMID 27744388 DOI: 10.1093/Aje/Kww075 |
0.336 |
|
| 2016 |
Ferris RL, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, ... ... Gillison ML, et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. The New England Journal of Medicine. PMID 27718784 DOI: 10.1056/Nejmoa1602252 |
0.327 |
|
| 2016 |
Taberna M, Resteghini C, Swanson B, Pickard RK, Jiang B, Xiao W, Mena M, Kreinbrink P, Chio E, Gillison ML. Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma. Oral Oncology. 61: 55-61. PMID 27688105 DOI: 10.1016/J.Oraloncology.2016.08.009 |
0.501 |
|
| 2016 |
Chaturvedi AK, D'Souza G, Gillison ML, Katki HA. Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population. Oral Oncology. 60: 61-7. PMID 27531874 DOI: 10.1016/J.Oraloncology.2016.06.006 |
0.575 |
|
| 2016 |
Zhang Y, Waterboer T, Pawlita M, Sugar E, Minkoff H, Cranston RD, Wiley D, Burk R, Reddy S, Margolick J, Strickler H, Weber K, Gillison M, D'Souza G. Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection. Cancer Epidemiology. 43: 30-34. PMID 27344614 DOI: 10.1016/J.Canep.2016.06.002 |
0.584 |
|
| 2016 |
Gillison ML. Human Papillomavirus and Oropharyngeal Cancer Stage. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 1833-5. PMID 27114590 DOI: 10.1200/Jco.2016.66.6081 |
0.415 |
|
| 2016 |
Kahn JA, Rudy BJ, Xu J, Kapogiannis B, Secord E, Gillison M. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth. Journal of Medical Virology. PMID 27096166 DOI: 10.1002/Jmv.24555 |
0.468 |
|
| 2016 |
Lam JO, Bream JH, Sugar EA, Coles CL, Weber KM, Burk RD, Wiley DJ, Cranston RD, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Guo Y, Xiao W, ... Gillison ML, et al. Association of serum cytokines with oral HPV clearance. Cytokine. 83: 85-91. PMID 27064455 DOI: 10.1016/J.Cyto.2016.04.002 |
0.55 |
|
| 2016 |
D'Souza G, Wentz A, Kluz N, Zhang Y, Sugar E, Youngfellow RM, Guo Y, Xiao W, Gillison ML. Gender differences in risk factors and natural history of oral human papillomavirus (HPV) infection. The Journal of Infectious Diseases. PMID 26908748 DOI: 10.1093/Infdis/Jiw063 |
0.538 |
|
| 2016 |
Rollison DE, Gillison ML. The Alpha, Beta, Gammas of Oral Human Papillomavirus Infection and Head and Neck Cancer Risk. Jama Oncology. PMID 26797496 DOI: 10.1001/Jamaoncol.2015.5686 |
0.388 |
|
| 2016 |
Li S, Ferris RL, Holsinger FC, Weinstein GS, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Wagner LI, Ringash J, Lewin JS, Mendez E, Ridge JA, Richmon J, et al. E3311 trial of transoral surgery for oropharynx cancer: Implementation of a novel surgeon credentialing and quality assurance process. Journal of Clinical Oncology. 34: 6054-6054. DOI: 10.1200/Jco.2016.34.15_Suppl.6054 |
0.332 |
|
| 2016 |
Fakhry C, Zhang Q, Gillison ML, Nguyen PD, Rosenthal DI, Weber RS, Lambert L, Trotti A, Barrett W, Thorstad W, Yom SS, Wong SJ, Ridge JA, Rao SS, Bonner JA, et al. Predicting overall survival (OS) and progression-free (PFS) for oropharynx cancers (OPC) in NRG Oncology RTOG0129/0522 with nomograms. Journal of Clinical Oncology. 34: 6024-6024. DOI: 10.1200/Jco.2016.34.15_Suppl.6024 |
0.468 |
|
| 2016 |
Ferris RL, Blumenschein GR, Fayette J, Guigay J, Colevas AD, Licitra LF, Harrington KJ, Kasper S, Vokes EE, Even C, Worden FP, Haddad RI, Kiyota N, Tahara M, Monga M, ... ... Gillison ML, et al. Further evaluations of nivolumab (nivo) versus investigator’s choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CheckMate 141. Journal of Clinical Oncology. 34: 6009-6009. DOI: 10.1200/Jco.2016.34.15_Suppl.6009 |
0.323 |
|
| 2016 |
Gillison ML, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, et al. Abstract CT099: Nivolumab (nivo) vs investigator's choice (IC) for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): CheckMate-141 Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct099 |
0.376 |
|
| 2016 |
Symer DE, Akagi K, Coombes KR, Xiao W, Pickard RKL, Agrawal A, Gillison ML. Abstract 132: Comprehensive genomic analysis of human papillomavirus-associated oral cancers Cancer Research. 76: 132-132. DOI: 10.1158/1538-7445.Am2016-132 |
0.538 |
|
| 2016 |
Haddad R, Gillison M, Ferris R, Harrington K, Monga M, Baudelet C, Geese W, Argiris A. Double-blind, two-arm, phase 2 study of nivolumab (nivo) in combination with ipilimumab (ipi) versus nivo and ipi-placebo (PBO) as first-line (1L) therapy in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)—CheckMate 714 Annals of Oncology. 27: vi350. DOI: 10.1093/Annonc/Mdw376.69 |
0.336 |
|
| 2016 |
Argiris A, Gillison M, Ferris R, Harrington K, Sanchez T, Baudelet C, Geese W, Shaw J, Haddad R. A randomized, open-label, phase 3 study of nivolumab in combination with ipilimumab vs extreme regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as first-line therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-CheckMate 651 Annals of Oncology. 27: vi350. DOI: 10.1093/Annonc/Mdw376.68 |
0.352 |
|
| 2016 |
Fakhry C, Zang Q, Gillison M, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti A, Barrett WL, Thorstad W, Yom SS, Wong S, Ridge JA, Rao SSD, Huh WK, et al. Prognostic Groups for p16-Positive Oropharyngeal Squamous Cell Cancer (p16-OPSCC) Treated With Chemoradiation Therapy (CRT) in NRG Oncology/RTOG 0129 and 0522 International Journal of Radiation Oncology Biology Physics. 94: 873-874. DOI: 10.1016/J.Ijrobp.2015.12.041 |
0.359 |
|
| 2016 |
Fakhry C, Zang Q, Gillison M, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti A, Barrett WL, Thorstad W, Yom SS, Wong S, Ridge JA, Rao SSD, Huh WK, et al. Validation of NRG Oncology/RTOG 0129 Risk Groups for p16-Positive and p16-Negative Oropharyngeal Squamous Cell Cancer (OPSCC) International Journal of Radiation Oncology Biology Physics. 94: 871. DOI: 10.1016/J.Ijrobp.2015.12.036 |
0.373 |
|
| 2015 |
Fakhry C, Yom S, Gillison ML. Elective versus Therapeutic Neck Dissection in Oral Cancer. The New England Journal of Medicine. 373: 2476. PMID 26672855 DOI: 10.1056/Nejmc1511351#Sa2 |
0.403 |
|
| 2015 |
Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, et al. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. Bmc Infectious Diseases. 15: 544. PMID 26607224 DOI: 10.1186/S12879-015-1281-5 |
0.519 |
|
| 2015 |
Romick-Rosendale LE, Hoskins EE, Privette Vinnedge LM, Foglesong GD, Brusadelli MG, Potter SS, Komurov K, Brugmann SA, Lambert P, Kimple RJ, Virts EL, Hanenberg H, Gillison ML, Wells SI. Defects in the Fanconi anemia pathway in head and neck cancer cells stimulate tumor cell invasion through DNA-PK and Rac1 signaling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26603260 DOI: 10.1158/1078-0432.Ccr-15-2209 |
0.332 |
|
| 2015 |
Robbins HA, Fennell CE, Gillison M, Xiao W, Guo Y, Wentz A, Kirk GD, Mehta SH, D'Souza G. Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs. Plos One. 10: e0143698. PMID 26600158 DOI: 10.1371/Journal.Pone.0143698 |
0.545 |
|
| 2015 |
Yom SS, Gillison ML, Trotti AM. Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder. International Journal of Radiation Oncology, Biology, Physics. 93: 986-8. PMID 26581136 DOI: 10.1016/J.Ijrobp.2015.09.002 |
0.589 |
|
| 2015 |
Gillison ML, Restighini C. Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient. Hematology/Oncology Clinics of North America. 29: 1045-60. PMID 26568547 DOI: 10.1016/J.Hoc.2015.08.003 |
0.578 |
|
| 2015 |
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 3235-42. PMID 26351338 DOI: 10.1200/Jco.2015.61.6995 |
0.624 |
|
| 2015 |
Fakhry C, Andersen KK, Eisele DW, Gillison ML. Oropharyngeal cancer survivorship in Denmark, 1977-2012. Oral Oncology. PMID 26319353 DOI: 10.1016/J.Oraloncology.2015.08.006 |
0.554 |
|
| 2015 |
Boffetta P, Hayes RB, Sartori S, Lee YA, Muscat J, Olshan A, Winn DM, Castellsagué X, Zhang ZF, Morgenstern H, Chen C, Schwartz SM, Vaughan TL, Wunsch-Filho V, Purdue M, ... ... Gillison M, et al. Mouthwash use and cancer of the head and neck: a pooled analysis from the International Head and Neck Cancer Epidemiology Consortium. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). PMID 26275006 DOI: 10.1097/Cej.0000000000000179 |
0.392 |
|
| 2015 |
Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Fakhry C, Quon H, Sikora AG, Stott WJ, Lorch JH, Gourin CG, Guo Y, Xiao W, Miles BA, et al. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. Jama Oncology. PMID 26226294 DOI: 10.1001/Jamaoncol.2015.2524 |
0.584 |
|
| 2015 |
Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, et al. Head and Neck Cancers, Version 1.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 847-56. PMID 26150579 DOI: 10.6004/Jnccn.2015.0102 |
0.348 |
|
| 2015 |
Anderson KS, Gerber JE, D'Souza G, Pai SI, Cheng JN, Alam R, Kesiraju S, Chowell D, Gross ND, Haddad R, Gillison ML, Posner M. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study. Oral Oncology. PMID 26094591 DOI: 10.1016/J.Oraloncology.2015.05.007 |
0.586 |
|
| 2015 |
Beachler DC, Guo Y, Xiao W, Burk RD, Minkoff H, Strickler HD, Cranston RD, Wiley DJ, Jacobson LP, Weber KM, Margolick JB, Sugar EA, Reddy S, Gillison ML, D'Souza G. High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection. The Journal of Infectious Diseases. PMID 25954049 DOI: 10.1093/Infdis/Jiv273 |
0.551 |
|
| 2015 |
Chaturvedi AK, Graubard BI, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Gillison ML. NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men. Cancer Research. 75: 2468-77. PMID 25873485 DOI: 10.1158/0008-5472.Can-14-2843 |
0.461 |
|
| 2015 |
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth. Sexually Transmitted Diseases. 42: 246-52. PMID 25868136 DOI: 10.1097/Olq.0000000000000264 |
0.565 |
|
| 2015 |
Beachler DC, Viscidi R, Sugar EA, Minkoff H, Strickler HD, Cranston RD, Wiley DJ, Jacobson LP, Weber KM, Margolick JB, Reddy S, Gillison ML, D'Souza G. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection. Sexually Transmitted Diseases. 42: 93-7. PMID 25585068 DOI: 10.1097/Olq.0000000000000236 |
0.485 |
|
| 2015 |
Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 156-64. PMID 25488965 DOI: 10.1200/Jco.2014.56.5218 |
0.377 |
|
| 2015 |
Beachler DC, Sugar EA, Margolick JB, Weber KM, Strickler HD, Wiley DJ, Cranston RD, Burk RD, Minkoff H, Reddy S, Xiao W, Guo Y, Gillison ML, D'Souza G. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. American Journal of Epidemiology. 181: 40-53. PMID 25480823 DOI: 10.1093/Aje/Kwu247 |
0.52 |
|
| 2015 |
Conway DI, Brenner DR, McMahon AD, Macpherson LM, Agudo A, Ahrens W, Bosetti C, Brenner H, Castellsague X, Chen C, Curado MP, Curioni OA, Dal Maso L, Daudt AW, de Gois Filho JF, ... ... Gillison M, et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. International Journal of Cancer. Journal International Du Cancer. 136: 1125-39. PMID 24996155 DOI: 10.1002/Ijc.29063 |
0.353 |
|
| 2015 |
Adams AK, Hallenbeck GE, Casper KA, Patil YJ, Wilson KM, Kimple RJ, Lambert PF, Witte DP, Xiao W, Gillison ML, Wikenheiser-Brokamp KA, Wise-Draper TM, Wells SI. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation. Oncogene. 34: 868-77. PMID 24608431 DOI: 10.1038/Onc.2014.15 |
0.598 |
|
| 2015 |
Marur S, Wang H, Quon H, Chung CH, Gillison ML, Agrawal N, Richmon J, Subramaniam RM, Koch W, Gourin CG, Forastiere AA. A phase I (Ph1) study of dasatinib (D) with cetuximab (Cet) /radiation (IMRT) +/- cisplatin (P) in stage II, III/IV head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 33: e17036-e17036. DOI: 10.1200/Jco.2015.33.15_Suppl.E17036 |
0.331 |
|
| 2015 |
Cmelak A, Li S, Marur S, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Murphy BA, Galloway T, Burtness B. Symptom reduction from IMRT dose deintensification: Results from ECOG 1308 using the Vanderbilt Head and Neck Symptom Survey version 2 (VHNSS V2). Journal of Clinical Oncology. 33: 6021-6021. DOI: 10.1200/Jco.2015.33.15_Suppl.6021 |
0.378 |
|
| 2015 |
Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Quon H, Sikora AG, Stott W, Lorch JH, Gourin CG, Miles B, Richmon J, Misiukiewicz K, Chung CH, et al. Prognostic implication of persistent HPV16 DNA detection in oral rinses for HPV-positive oropharyngeal carcinoma. Journal of Clinical Oncology. 33: 6005-6005. DOI: 10.1200/Jco.2015.33.15_Suppl.6005 |
0.579 |
|
| 2014 |
Li S, Marur S, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Colevas AD, Jahagirdar BN, Burtness B. E1308: Reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction chemotherapy (IC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: LBA6006. PMID 28141977 DOI: 10.1200/Jco.2014.32.18_Suppl.Lba6006 |
0.518 |
|
| 2014 |
Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, ... Gillison ML, et al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3858-66. PMID 25366680 DOI: 10.1200/Jco.2014.55.3925 |
0.325 |
|
| 2014 |
Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, et al. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1454-87. PMID 25313184 DOI: 10.6004/Jnccn.2014.0142 |
0.356 |
|
| 2014 |
Fakhry C, Gillison ML, D'Souza G. Tobacco use and oral HPV-16 infection. Jama. 312: 1465-7. PMID 25291584 DOI: 10.1001/Jama.2014.13183 |
0.536 |
|
| 2014 |
Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan RC, Le QT. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3930-8. PMID 25267748 DOI: 10.1200/Jco.2013.54.5228 |
0.576 |
|
| 2014 |
D'Souza G, Kluz N, Wentz A, Youngfellow RM, Griffioen A, Stammer E, Guo Y, Xiao W, Gillison ML. Oral Human Papillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults. Cancers. 6: 1691-704. PMID 25256827 DOI: 10.3390/Cancers6031691 |
0.577 |
|
| 2014 |
Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2940-50. PMID 25154822 DOI: 10.1200/Jco.2013.53.5633 |
0.313 |
|
| 2014 |
Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang K. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2486-95. PMID 25002723 DOI: 10.1200/Jco.2013.53.9163 |
0.365 |
|
| 2014 |
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3365-73. PMID 24958820 DOI: 10.1200/Jco.2014.55.1937 |
0.509 |
|
| 2014 |
Fakhry C, Agrawal N, Califano J, Messing B, Liu J, Saunders J, Ha P, Coquia S, Hamper U, Gillison M, Blanco R. The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers. Oral Oncology. 50: 640-5. PMID 24819862 DOI: 10.1016/J.Oraloncology.2014.03.015 |
0.349 |
|
| 2014 |
D'Souza G, Gross ND, Pai SI, Haddad R, Anderson KS, Rajan S, Gerber J, Gillison ML, Posner MR. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2408-15. PMID 24778397 DOI: 10.1200/Jco.2014.55.1341 |
0.609 |
|
| 2014 |
Chaturvedi AK, Graubard BI, Pickard RK, Xiao W, Gillison ML. High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010. The Journal of Infectious Diseases. 210: 441-7. PMID 24625808 DOI: 10.1093/Infdis/Jiu116 |
0.528 |
|
| 2014 |
Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, Markowitz LE, Unger ER. Prevalence of cervical and oral human papillomavirus infections among US women. The Journal of Infectious Diseases. 209: 1739-43. PMID 24319284 DOI: 10.1093/Infdis/Jit799 |
0.548 |
|
| 2014 |
Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison ML. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Research. 24: 185-99. PMID 24201445 DOI: 10.1101/Gr.164806.113 |
0.534 |
|
| 2014 |
Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi S. Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. International Journal of Cancer. Journal International Du Cancer. 134: 497-507. PMID 23568556 DOI: 10.1002/Ijc.28201 |
0.624 |
|
| 2014 |
Savvides P, Kumar P, Gillison ML, Teknos T. A phase I/II clinical trial of sorafenib in combination with cisplatin and docetaxel in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps6103 |
0.342 |
|
| 2014 |
Fakhry C, Agrawal N, Califano J, Coquia S, Hamper U, Saunders J, Messing B, Ha P, Gillison M, Blanco R. Ultrasound in the Search for the Primary Site of Unknown Primary Head-and-Neck Squamous Cell Cancers International Journal of Radiation Oncology Biology Physics. 88: 499. DOI: 10.1016/J.Ijrobp.2013.11.115 |
0.378 |
|
| 2014 |
Fakhry C, Zhang Q, Nguyen-Tân P, Rosenthal D, El-Naggar A, Garden A, Soulieres D, Harris J, Le Q, Gillison M. Human Papillomavirus (HPV) and Overall Survival (OS) After Progression of Oropharyngeal Squamous Cell Carcinoma (OPSCC) International Journal of Radiation Oncology Biology Physics. 88: 466. DOI: 10.1016/J.Ijrobp.2013.11.023 |
0.498 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: H1-31. PMID 24332295 DOI: 10.1016/j.vaccine.2013.10.003 |
0.511 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: G1-31. PMID 24331817 DOI: 10.1016/j.vaccine.2013.10.002 |
0.511 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: F1-31. PMID 24331745 DOI: 10.1016/j.vaccine.2013.10.001 |
0.511 |
|
| 2013 |
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4550-9. PMID 24248688 DOI: 10.1200/Jco.2013.50.3870 |
0.513 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: I1-31. PMID 24229716 DOI: 10.1016/J.Vaccine.2013.07.026 |
0.587 |
|
| 2013 |
Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 917-23. PMID 23946171 DOI: 10.6004/Jnccn.2013.0113 |
0.378 |
|
| 2013 |
Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison ML. Natural history of anal vs oral HPV infection in HIV-infected men and women. The Journal of Infectious Diseases. 208: 330-9. PMID 23596319 DOI: 10.1093/Infdis/Jit170 |
0.578 |
|
| 2013 |
Perez-Ordoñez B, Irish JC, Yu ES, Gillison ML. Human papillomavirus-16 associated adenocarcinoma NOS of base of tongue. Head and Neck Pathology. 7: 268-73. PMID 23054956 DOI: 10.1007/S12105-012-0404-1 |
0.594 |
|
| 2013 |
Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncology. 49: 1-8. PMID 22841678 DOI: 10.1016/J.Oraloncology.2012.07.002 |
0.596 |
|
| 2013 |
D'Souza G, Gross ND, Pai SI, Haddad RI, Gillison ML, Posner MR. Oral HPV infection in HPV-positive oropharyngeal cancer cases and their spouses. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.Cra6031 |
0.601 |
|
| 2013 |
Chung CH, Zhang Q, Kong C, Harris J, Ang KK, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan R, Le Q. p16 expression as a human papillomavirus (HPV)-independent prognostic biomarker in non-oropharyngeal squamous cell carcinoma (non-OPSCC). Journal of Clinical Oncology. 31: 6007-6007. DOI: 10.1200/Jco.2013.31.15_Suppl.6007 |
0.576 |
|
| 2013 |
Marur S, Li S, Cmelak A, Gillison ML, Ferris RL, Bauman JE, Zhao W, Westra WH, Chung CH, Wagner LI, Trevarthen DR, Jahagirdar BN, Colevas AD, Burtness B. E 1308: A phase II trial of induction chemotherapy (IC) followed by cetuximab with low dose versus standard dose IMRT in patients with human papilloma virus (HPV)-associated resectable squamous cell carcinoma of the oropharynx (OPSCC). Journal of Clinical Oncology. 31: 6005-6005. DOI: 10.1200/Jco.2013.31.15_Suppl.6005 |
0.506 |
|
| 2012 |
Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsagué X. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 30: F34-54. PMID 23199965 DOI: 10.1016/J.Vaccine.2012.05.070 |
0.625 |
|
| 2012 |
Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. The American Journal of Surgical Pathology. 36: 945-54. PMID 22743284 DOI: 10.1097/Pas.0B013E318253A2D1 |
0.569 |
|
| 2012 |
Pickard RK, Xiao W, Broutian TR, He X, Gillison ML. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sexually Transmitted Diseases. 39: 559-66. PMID 22706220 DOI: 10.1097/Olq.0B013E31824F1C65 |
0.509 |
|
| 2012 |
Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Butsch Kovacic M, Wikenheiser-Brokamp KA, et al. The fanconi anemia pathway limits human papillomavirus replication. Journal of Virology. 86: 8131-8. PMID 22623785 DOI: 10.1128/Jvi.00408-12 |
0.576 |
|
| 2012 |
Arbyn M, De Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease International Journal of Cancer. 131: 1969-1982. PMID 22623137 DOI: 10.1002/Ijc.27650 |
0.6 |
|
| 2012 |
Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2102-11. PMID 22565003 DOI: 10.1200/Jco.2011.38.4099 |
0.326 |
|
| 2012 |
Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. Jama. 307: 693-703. PMID 22282321 DOI: 10.1001/Jama.2012.101 |
0.464 |
|
| 2012 |
Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, Wiley DJ, Minkoff H, Reddy S, Stammer EE, Gillison ML, D'Souza G. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 122-33. PMID 22045700 DOI: 10.1158/1055-9965.Epi-11-0734 |
0.493 |
|
| 2012 |
Fakhry C, Bajaj G, Aygun N, Westra W, Gillison M. Long-Term Survival Of A Patient With Leptomeningeal Involvement By Nasopharyngeal Carcinoma After Treatment With High-Dose Intravenous Methotrexate Head and Neck-Journal For the Sciences and Specialties of the Head and Neck. 34: 296-300. PMID 20737501 DOI: 10.1002/Hed.21516 |
0.327 |
|
| 2012 |
Marur S, Lee J, Cmelak A, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Colevas AD, Jahagirdar BN, Burtness B. ECOG 1308: A phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). Journal of Clinical Oncology. 30: 5566-5566. DOI: 10.1200/Jco.2012.30.15_Suppl.5566 |
0.575 |
|
| 2012 |
Wuthrick EJ, Zhang Q, Machtay M, Ang KK, Rosenthal DI, Nguyen-Tan F, Fortin A, Silverman CI, Raben A, Kim H, Horwitz EM, Read NE, Harris J, Wu Q, Gillison ML. The influence of institutional head and neck cancer (HNC) clinical trial accrual on overall survival (OS): An analysis of RTOG 0129. Journal of Clinical Oncology. 30: 5530-5530. DOI: 10.1200/Jco.2012.30.15_Suppl.5530 |
0.365 |
|
| 2012 |
Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Chaudhry MA, Wahl R, Forastiere A, Gillison M. Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742)) Clinical Cancer Research. 18: 3998. DOI: 10.1158/1078-0432.Ccr-12-1736 |
0.378 |
|
| 2012 |
Newcomb M, Kramer S, Hessler JD, Grecula JC, Gillison ML, Neki A, Siddiqui F. Comparison of Weekly and 3-weekly Cisplatin-based Chemoradiation Therapy Regimens for the Treatment of Patients With Stage III/IV Squamous Cell Head-and-Neck Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1249 |
0.389 |
|
| 2011 |
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, ... ... Gillison ML, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4294-301. PMID 21969503 DOI: 10.1200/Jco.2011.36.4596 |
0.534 |
|
| 2011 |
Fakhry C, Rosenthal BT, Clark DP, Gillison ML. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prevention Research (Philadelphia, Pa.). 4: 1378-84. PMID 21836021 DOI: 10.1158/1940-6207.Capr-11-0284 |
0.596 |
|
| 2011 |
Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, et al. Head and neck cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 596-650. PMID 21636536 DOI: 10.6004/Jnccn.2011.0053 |
0.383 |
|
| 2011 |
Koshiol J, Rotunno M, Gillison ML, Van Doorn LJ, Chaturvedi AK, Tarantini L, Song H, Quint WG, Struijk L, Goldstein AM, Hildesheim A, Taylor PR, Wacholder S, Bertazzi PA, Landi MT, et al. Assessment of human papillomavirus in lung tumor tissue. Journal of the National Cancer Institute. 103: 501-7. PMID 21293027 DOI: 10.1093/Jnci/Djr003 |
0.513 |
|
| 2011 |
Broutian TR, He X, Gillison ML. Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 50: 270-5. PMID 21273118 DOI: 10.1016/J.Jcv.2010.12.005 |
0.539 |
|
| 2011 |
Jordan R, Gillison M, Zante Av. Oropharyngeal carcinoma: A unique human papillomavirus-associated tumor of the head and neck Pathology Case Reviews. 16: 173-175. DOI: 10.1097/Pcr.0B013E3182248B4F |
0.418 |
|
| 2010 |
Fakhry C, Sugar E, D'Souza G, Gillison M. Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. Plos One. 5: e11918. PMID 20689835 DOI: 10.1371/Journal.Pone.0011918 |
0.54 |
|
| 2010 |
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. The New England Journal of Medicine. 363: 24-35. PMID 20530316 DOI: 10.1056/Nejmoa0912217 |
0.584 |
|
| 2010 |
D'Souza G, Zhang HH, D'Souza WD, Meyer RR, Gillison ML. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncology. 46: 100-4. PMID 20036610 DOI: 10.1016/J.Oraloncology.2009.11.004 |
0.577 |
|
| 2010 |
Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS, Abnet CC, Wang JB, Kamangar F, Lin DM, von Knebel-Doeberitz M, Zhang Y, Viscidi R, Wang GQ, Gillison ML, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of Cancer. Journal International Du Cancer. 127: 93-100. PMID 19918949 DOI: 10.1002/Ijc.25023 |
0.569 |
|
| 2010 |
Koshiol J, Rotunno M, Gillison M, Doorn Lv, Tarantini L, Song H, Quint W, Struijk L, Goldstein A, Chaturvedi A, Hildesheim A, Taylor P, Wacholder S, Bertazzi PA, Landi MT, et al. Abstract 4824: Little evidence of human papillomavirus in lung tumor tissue Cancer Research. 70: 4824-4824. DOI: 10.1158/1538-7445.Am10-4824 |
0.563 |
|
| 2009 |
Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, O'Sullivan B, Waldron J, Cummings B, Kim J, Ringash J, Dawson LA, Gullane P, Siu L, Gillison M, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6213-21. PMID 19884544 DOI: 10.1200/Jco.2009.23.1670 |
0.571 |
|
| 2009 |
Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6758-62. PMID 19861444 DOI: 10.1158/1078-0432.Ccr-09-0784 |
0.596 |
|
| 2009 |
Gillison ML. HPV and prognosis for patients with oropharynx cancer. European Journal of Cancer (Oxford, England : 1990). 45: 383-5. PMID 19775640 DOI: 10.1016/S0959-8049(09)70058-9 |
0.59 |
|
| 2009 |
Gillison ML. Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Current Opinion in Oncology. 21: 439-44. PMID 19587593 DOI: 10.1097/Cco.0B013E32832F3E1B |
0.544 |
|
| 2009 |
D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. The Journal of Infectious Diseases. 199: 1263-9. PMID 19320589 DOI: 10.1086/597755 |
0.538 |
|
| 2008 |
Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematology/Oncology Clinics of North America. 22: 1125-42, vii. PMID 19010263 DOI: 10.1016/J.Hoc.2008.08.006 |
0.6 |
|
| 2008 |
Agrawal Y, Koch WM, Xiao W, Westra WH, Trivett AL, Symer DE, Gillison ML. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7143-50. PMID 18981014 DOI: 10.1158/1078-0432.Ccr-08-0498 |
0.604 |
|
| 2008 |
Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 113: 3036-46. PMID 18980286 DOI: 10.1002/Cncr.23764 |
0.596 |
|
| 2008 |
Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 113: 2901-9. PMID 18980273 DOI: 10.1002/Cncr.23745 |
0.577 |
|
| 2008 |
Gillison ML. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 43: S52-60. PMID 18809146 DOI: 10.1016/J.Jadohealth.2008.07.002 |
0.591 |
|
| 2008 |
Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Journal of the National Cancer Institute. 100: 407-20. PMID 18334711 DOI: 10.1093/Jnci/Djn025 |
0.58 |
|
| 2008 |
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Journal of the National Cancer Institute. 100: 261-9. PMID 18270337 DOI: 10.1093/Jnci/Djn011 |
0.561 |
|
| 2008 |
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 612-9. PMID 18235120 DOI: 10.1200/Jco.2007.14.1713 |
0.593 |
|
| 2007 |
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. The New England Journal of Medicine. 356: 1944-56. PMID 17494927 DOI: 10.1056/Nejmoa065497 |
0.592 |
|
| 2007 |
D'Souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkoff HL, Anastos K, Palefsky JM, Gillison ML. Six-month natural history of oral versus cervical human papillomavirus infection. International Journal of Cancer. Journal International Du Cancer. 121: 143-50. PMID 17354235 DOI: 10.1002/Ijc.22667 |
0.559 |
|
| 2007 |
Begum S, Gillison ML, Nicol TL, Westra WH. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1186-91. PMID 17317828 DOI: 10.1158/1078-0432.Ccr-06-1690 |
0.511 |
|
| 2007 |
Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head & Neck. 29: 779-92. PMID 17230556 DOI: 10.1002/Hed.20573 |
0.354 |
|
| 2007 |
Gillison ML, Chen R, Goshu E, Rushlow D, Chen N, Banister C, Creek KE, Gallie BL. Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor viruses. International Journal of Cancer. 120: 1482-90. PMID 17205527 DOI: 10.1002/Ijc.22516 |
0.389 |
|
| 2007 |
Ferris RL, Trask DK, Agrawal Y, Gillison M. 08:50: Predictive Value of Measures of HPV Exposure and Infection Otolaryngology–Head and Neck Surgery. 137: P57-P58. DOI: 10.1016/J.Otohns.2007.06.083 |
0.48 |
|
| 2006 |
Gillison ML. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 5623-5. PMID 17179099 DOI: 10.1200/Jco.2006.07.1829 |
0.601 |
|
| 2006 |
Fakhry C, D'souza G, Sugar E, Weber K, Goshu E, Minkoff H, Wright R, Seaberg E, Gillison M. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. Journal of Clinical Microbiology. 44: 4479-85. PMID 17021055 DOI: 10.1128/Jcm.01321-06 |
0.567 |
|
| 2006 |
Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine. 24: S3/140-6. PMID 16950001 DOI: 10.1016/J.Vaccine.2006.05.120 |
0.505 |
|
| 2006 |
Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2606-11. PMID 16763272 DOI: 10.1200/Jco.2006.06.1291 |
0.618 |
|
| 2005 |
D'Souza G, Sugar E, Ruby W, Gravitt P, Gillison M. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. Journal of Clinical Microbiology. 43: 5526-35. PMID 16272481 DOI: 10.1128/Jcm.43.11.5526-5535.2005 |
0.551 |
|
| 2005 |
Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5694-9. PMID 16115905 DOI: 10.1158/1078-0432.Ccr-05-0587 |
0.604 |
|
| 2004 |
Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Seminars in Oncology. 31: 744-54. PMID 15599852 DOI: 10.1053/J.Seminoncol.2004.09.011 |
0.614 |
|
| 2004 |
Gillison M, Lowy. A causal role for human papillomavirus in head and neck cancer. The Lancet. 363: 1488-1489. PMID 15135592 DOI: 10.1016/S0140-6736(04)16194-1 |
0.455 |
|
| 2004 |
Kreimer AR, Alberg AJ, Viscidi R, Gillison ML. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sexually Transmitted Diseases. 31: 247-56. PMID 15028941 DOI: 10.1097/01.Olq.0000118425.49522.2C |
0.569 |
|
| 2004 |
Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. The Journal of Infectious Diseases. 189: 686-98. PMID 14767823 DOI: 10.1086/381504 |
0.567 |
|
| 2004 |
Trimble C, Lin CT, Hung CF, Pai S, Juang J, He L, Gillison M, Pardoll D, Wu L, Wu TC. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine. 21: 4036-42. PMID 12922140 DOI: 10.1016/S0264-410X(03)00275-5 |
0.404 |
|
| 2003 |
Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 6469-75. PMID 14695150 |
0.388 |
|
| 2003 |
Lowy DR, Gillison ML. A new link between Fanconi anemia and human papillomavirus-associated malignancies. Journal of the National Cancer Institute. 95: 1648-50. PMID 14625250 DOI: 10.1093/Jnci/Djg125 |
0.369 |
|
| 2003 |
Devaraj K, Gillison ML, Wu TC. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Critical Reviews in Oral Biology and Medicine : An Official Publication of the American Association of Oral Biologists. 14: 345-62. PMID 14530303 DOI: 10.1177/154411130301400505 |
0.542 |
|
| 2003 |
Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. Journal of the National Cancer Institute. Monographs. 57-65. PMID 12807947 DOI: 10.1093/Oxfordjournals.Jncimonographs.A003484 |
0.589 |
|
| 2002 |
Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1203-9. PMID 12006539 |
0.517 |
|
| 2001 |
Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Current Opinion in Oncology. 13: 183-8. PMID 11307062 DOI: 10.1097/00001622-200105000-00009 |
0.588 |
|
| 2000 |
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers Journal of the National Cancer Institute. 92: 709-720. PMID 10793107 DOI: 10.1093/Jnci/92.9.709 |
0.591 |
|
| 1999 |
Gillison ML, Forastiere AA. Larynx preservation in head and neck cancers. A discussion of the National Comprehensive Cancer Network Practice Guidelines. Hematology-Oncology Clinics of North America. 13: 699-718. PMID 10494508 DOI: 10.1016/S0889-8588(05)70087-3 |
0.355 |
|
| 1999 |
Gillison ML, Koch WM, Shah KV. Human papillomavirus in head and neck squamous cell carcinoma: Are some head and neck cancers a sexually transmitted disease? Current Opinion in Oncology. 11: 191-199. PMID 10328594 DOI: 10.1097/00001622-199905000-00010 |
0.612 |
|
| Show low-probability matches. |